Afterschool Mentoring Program for Depression
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether participants need to stop taking their current medications.
What data supports the effectiveness of the treatment After School Plus for depression?
Research shows that school-based programs using cognitive behavioral therapy (CBT) can effectively reduce depressive symptoms in students, with effect sizes ranging from 0.21 to 1.40. Additionally, group mentoring programs that include CBT techniques have been shown to improve social problem-solving skills and reduce behavior problems in children.12345
How does the Afterschool Mentoring Program for Depression differ from other treatments for depression?
The Afterschool Mentoring Program for Depression is unique because it focuses on building supportive mentoring relationships to help reduce depressive symptoms in youth, rather than using traditional methods like medication or cognitive behavioral therapy (CBT). This program emphasizes the quality of the mentor-mentee relationship and provides personalized support, which can be particularly beneficial for adolescents experiencing depression.16789
What is the purpose of this trial?
Coming out of the COVID-19 pandemic many youth are experiencing declines in physical activity and worsening mental health (e.g., depression symptoms). These declines are exacerbated among underserved youth who experience greater barriers to health services and exposure to life stressors that put them at increased risk for impaired mental, emotional, and behavioral health. School-based afterschool programming is an important strategy to reach this population of youth and provides intervention at a time when youth are likely to otherwise be in environments not supportive of health. Further participation in extracurricular activities has been shown to be a protective factor for youth mental health. However, consistent with the Behavioral Theory of Depression, youth who are currently inactive and who have depression symptoms are unlikely to participate in afterschool programming on their own and likely require heightened positive reinforcement when they do attend to encourage retention. Given the high prevalence of youth who experience symptoms of depression and resource and staffing challenges faced by many schools, the level of support needed to engage students to consistently participate and benefit from afterschool programming is often beyond the capacity of school-based afterschool programs. In partnership with a local afterschool program for middle school students in a low resource community, we developed an augmented version of the current afterschool program in which college students are trained to mentor and assist in the afterschool program, expanding the capacity of the afterschool program to engage students.The mentoring intervention uses behavioral activation principles to help youth connect their behaviors with their mood and support youth to engage in behaviors that improve their mood, including physical activity. The main purpose of this study is to pilot the feasibility of the newly developed intervention.
Research Team
Katherine Hendel
Principal Investigator
University of Minnesota
Eligibility Criteria
This pilot study is for middle school students in a low-resource community who may be experiencing symptoms of depression and declines in physical activity, especially following the COVID-19 pandemic. The program aims to engage these youth through an augmented afterschool initiative.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Initial Program Phase
Middle school students participate in the after school program as usual
Enhanced Program Phase
Middle school students participate in the augmented after school program with mentoring
Follow-up
Participants are monitored for attendance, depression symptoms, and activity levels
Treatment Details
Interventions
- After School Plus
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Minnesota
Lead Sponsor